CRISIL Ltd. Upgraded to Hold by MarketsMOJO on Technical and Valuation Improvements

Quality Assessment: Strong Fundamentals Amid Moderate Growth

CRISIL continues to demonstrate robust operational quality, underpinned by high management efficiency and a net-debt-free balance sheet. The company reported a return on equity (ROE) of 27.03% in its latest financials, with a return on capital employed (ROCE) of 40.16%, indicating effective utilisation of shareholder funds and capital. These figures are particularly impressive within the capital markets industry, where such returns are a testament to strong governance and operational discipline.

Quarterly financial results for Q1 FY26-27 further reinforce this quality narrative. Net sales surged by 27.56% to ₹1,075.39 crores, while profit before tax (excluding other income) rose by 28.43% to ₹258.70 crores. Net profit after tax grew by 26.2% to ₹216.46 crores, reflecting solid earnings momentum. However, long-term sales growth remains modest, with a compound annual growth rate of 14.40% over the past five years, suggesting tempered expansion prospects.

Despite the strong profitability metrics, the company’s stock performance over the last year has been disappointing, with a negative return of 19.11%, underperforming the broader market indices such as the BSE500, which delivered a marginal 0.21% gain. This divergence highlights a disconnect between operational performance and market sentiment, possibly due to valuation concerns and technical factors.

Valuation: From Very Expensive to Expensive

The valuation profile of CRISIL has been revised from very expensive to expensive, reflecting a slight moderation in market pricing relative to fundamentals. The company currently trades at a price-to-earnings (PE) ratio of 36.88, which remains elevated but is more reasonable compared to its previous standing. The price-to-book value stands at 9.97, indicating a premium valuation consistent with its high return metrics but signalling limited margin for error.

Enterprise value multiples also suggest a premium stance: EV to EBIT at 29.65 and EV to EBITDA at 26.06, both higher than many peers but justified by CRISIL’s strong profitability and market position. The PEG ratio of 1.71 indicates that earnings growth is somewhat priced in, though not excessively so. Dividend yield remains modest at 1.61%, reflecting the company’s preference for reinvestment over high payout.

When compared with industry peers such as CARE Ratings and ICRA, CRISIL’s valuation is competitive but not the most expensive. CARE Ratings, for instance, is classified as very expensive with a PE of 29.88 but a lower PEG ratio of 1.24, while ICRA trades at a lower PE of 24.56 but a higher PEG of 2.54. This relative positioning supports the upgraded valuation grade, suggesting CRISIL is fairly priced within its sector context.

Financial Trend: Positive Quarterly Momentum Amid Mixed Long-Term Returns

CRISIL’s recent financial trend has been encouraging, with the company reporting strong quarterly growth in sales and profits. The Q1 FY26-27 results showed net sales growth of 27.56%, PBT growth of 28.43%, and PAT growth of 26.2%, signalling operational resilience and effective cost management. The company remains net-debt free, which enhances financial flexibility and reduces risk.

However, the longer-term financial trend presents a more nuanced picture. Over the past year, the stock has delivered a negative return of 19.11%, significantly underperforming the Sensex’s 5.68% decline and the BSE500’s marginal positive return. Over a three-year horizon, CRISIL has generated a 16.18% return, slightly above the Sensex’s 15.95%, and over five and ten years, the stock has outperformed the benchmark with returns of 52.20% and 120.46% respectively, though the ten-year return trails the Sensex’s 174.18%.

This mixed performance suggests that while the company’s fundamentals remain strong, market sentiment and external factors have weighed on its stock price in the short term. The PEG ratio of 1.7 also indicates that earnings growth is somewhat priced in, but the market remains cautious.

Technical Analysis: Shift to Mildly Bearish Signals

The technical outlook for CRISIL has shifted, prompting a downgrade in the technical grade and influencing the overall rating upgrade to Hold. The technical trend has moved from sideways to mildly bearish, reflecting recent price action and momentum indicators.

Key technical indicators present a mixed picture. The weekly MACD remains mildly bullish, but the monthly MACD is bearish, indicating short-term strength but longer-term weakness. The Relative Strength Index (RSI) shows no clear signal on both weekly and monthly charts, suggesting indecision among traders.

Bollinger Bands are bullish on the weekly timeframe but mildly bearish monthly, while moving averages on the daily chart are mildly bearish. The KST indicator is mildly bullish weekly but bearish monthly, and Dow Theory shows no trend weekly but mildly bullish monthly. On-balance volume (OBV) is neutral weekly but bullish monthly, indicating accumulation over the longer term despite short-term selling pressure.

Price action on 28 July 2026 saw the stock rise 3.10% to ₹4,485.30, with a daily high of ₹4,500.00 and low of ₹4,325.75. The 52-week range remains wide, from ₹3,689.00 to ₹5,549.85, reflecting volatility and investor uncertainty.

Conclusion: A Balanced Upgrade Reflecting Strengths and Caution

The upgrade of CRISIL Ltd.’s investment rating from Sell to Hold reflects a balanced reassessment of its quality, valuation, financial trend, and technical outlook. The company’s strong profitability, high management efficiency, and net-debt-free status underpin a solid quality foundation. Valuation remains expensive but has moderated from very expensive, aligning more closely with peers and justifying a Hold stance rather than a Sell.

Financially, recent quarterly results demonstrate positive momentum, though longer-term stock returns have been mixed, with underperformance over the past year contrasting with solid multi-year gains. Technically, the shift to mildly bearish signals tempers enthusiasm, suggesting caution in the near term.

Investors should weigh CRISIL’s robust fundamentals against valuation premiums and technical uncertainties. While the company remains a quality player in the capital markets sector, the Hold rating signals that the stock may not yet offer compelling upside relative to risk, especially given its recent price volatility and market underperformance.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →